Vitabalans Pharma OÜRegistered
Annual report for 2025 not filed.
Key figures
1 141 472 €+10,9%
Revenue 2024
+14,2%
Average annual growth 2019–2024
Ratios
20243,9%
Profit margin
5,1%
EBITDA margin
30,3%
Equity ratio
1,4×
Current ratio
76,9%
Return on equity
7211 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 289 156 € | 2 | 24 619 € |
| Q1 2026 | 281 422 € | 2 | 23 368 € |
| Q4 2025 | 277 691 € | 2 | 27 871 € |
| Q3 2025 | 271 528 € | 2 | 24 488 € |
| Q2 2025 | 301 880 € | 2 | 28 137 € |
| Q1 2025 | 286 324 € | 2 | 24 908 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculated2024
Distributed as dividends 42 261 € (80% of distributable profit).
History
202442 261 €
202345 000 €
202273 100 €
202185 582 €
2020240 000 €
Previous year's retained earnings + previous year's profit − current retained earnings.
Summary of financial statements2019–2024
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||
| Total current assets | 488 058 | 268 184 | 182 470 | 151 595 | 179 824 | 186 057 |
| Total non-current assets | 21 931 | 9969 | 15 965 | 12 209 | 8452 | 4696 |
| Total assets | 509 989 | 278 153 | 198 435 | 163 804 | 188 276 | 190 753 |
| Balance sheet — liabilities and equity | ||||||
| Current liabilities | 73 563 | 111 252 | 94 750 | 104 844 | 132 638 | 132 897 |
| Non-current liabilities | — | — | — | — | — | — |
| Total liabilities | 73 563 | 111 252 | 94 750 | 104 844 | 132 638 | 132 897 |
| Share capital | 2556 | 2556 | 2556 | 2556 | 2556 | 2556 |
| Retained earnings of previous periods | 405 627 | 193 614 | 78 507 | 27 773 | 11 148 | 10 565 |
| Profit for the year | 27 987 | −29 525 | 22 366 | 28 375 | 41 678 | 44 479 |
| Reserves and other equity | 256 | 256 | 256 | 256 | 256 | 256 |
| Total equity | 436 426 | 166 901 | 103 685 | 58 960 | 55 638 | 57 856 |
| Income statement | ||||||
| Sales revenue | 587 728 | 639 974 | 737 485 | 845 770 | 1 029 072 | 1 141 472 |
| Operating profit | 27 987 | 30 475 | 36 785 | 40 275 | 49 004 | 54 356 |
| EBITDA | 39 950 | 42 437 | 49 571 | 44 031 | 52 761 | 58 112 |
| Profit before income tax | 27 987 | 30 475 | 36 785 | 40 275 | 49 004 | 54 356 |
| Profit for the reporting year | 27 987 | −29 525 | 22 366 | 28 375 | 41 678 | 44 479 |
| Labour costs | 170 702 | 165 343 | 196 414 | 173 266 | 206 194 | 228 258 |
| Depreciation of non-current assets | 11 963 | 11 962 | 12 786 | 3756 | 3757 | 3756 |
| Other indicators | ||||||
| Employees | 3 | 3 | 3 | 2 | 2 | 2 |
| Calculated dividend | — | 240 000 | 85 582 | 73 100 | 45 000 | 42 261 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
CompanyPersonShareholderOther roleAdditional link
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
Same activity — Mujal liigitamata äritegevust abistavate tegevuste vahendamine
Same address